Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Clinical trial NCT06071767 · RECRUITING
Trial details
- NCT number
- NCT06071767
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2028-04-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.